Wille, T; Müller, B; Noth, D; Bürgi, U; Diem, P (2006). [Long-term follow up after antithyroid drug treatment in Graves' disease]. Praxis - schweizerische Rundschau für Medizin, 95(29-30), pp. 1121-7. Bern: Huber
Full text not available from this repository. (Request a copy)In Europe antithyroid drug (ATD) therapy is the preferred initial treatment for patients with a first episode of Graves' disease. Results of long-term recurrence rates following ATD therapy are conflicting. The main goal was to assess long-term recurrence rate after ATD treatment. Secondarily we tried to verify chemical and clinical findings (thyrotropin receptor antibodies (TRAb), duration of primary treatment, age and goitre size) as predictive factors.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine 04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition |
UniBE Contributor: |
Bürgi, Ulrich, Diem, Peter |
ISSN: |
1661-8157 |
ISBN: |
16916174 |
Publisher: |
Huber |
Language: |
German |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:46 |
Last Modified: |
05 Dec 2022 14:14 |
PubMed ID: |
16916174 |
URI: |
https://boris.unibe.ch/id/eprint/19070 (FactScience: 1438) |
Actions (login required)
 |
Edit item |